Medgend Icon

Ledgend of Medicine







discontinued


Atropine Sulfate

Amblyopia, or "lazy eye," is the most common cause of visual impairment in children. It happens when an eye fails to work properly with the brain. The eye may look normal, but the brain favors the other eye. In some cases, it can affect both eyes. Causes include:

  • Strabismus - a disorder in which the two eyes don't line up in the same direction
  • Refractive error in an eye - when one eye cannot focus as well as the other, because of a problem with its shape. This includes nearsightedness, farsightedness, and astigmatism.
  • Cataract - a clouding in the lens of the eye

It can be hard to diagnose amblyopia. It is often found during a routine vision exam.

Treatment for amblyopia forces the child to use the eye with weaker vision. There are two common ways to do this. One is to have the child wear a patch over the good eye for several hours each day, over a number of weeks to months. The other is with eye drops that temporarily blur vision. Each day, the child gets a drop of a drug called atropine in the stronger eye. It is also sometimes necessary to treat the underlying cause. This could include glasses or surgery.

NIH: National Eye Institute

Atropine Sulfate FDA Approved Drugs

ATROPINE SULFATE [Atropine Sulfate2C17H23NO3H2OH2O4S]
RX
-
1% (ophthalmic solution/drops)
AkornJul 18, 2014
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ATROPINE SULFATE ANSYR PLASTIC SYRINGE [Atropine Sulfate2C17H23NO3H2OH2O4S]
RX
-
0.05mg/ml (intramuscular, intravenous, subcutaneous injectable)
0.1mg/ml (intramuscular, intravenous, subcutaneous injectable)
HospiraJul 9, 2001
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE [Atropine Sulfate2C17H23NO3H2OH2O4S : Diphenoxylate HydrochlorideC30H32N2O2ClH]
RX
-
0.025mg/5ml : 2.5mg/5ml (oral solution)
0.025mg : 2.5mg (oral tablet)
West-ward Pharms IntMay 3, 1982
Ani Pharms IncApproved Prior To Jan 1, 1982
LannettApproved Prior To Jan 1, 1982
MylanApproved Prior To Jan 1, 1982
Par PharmMay 2, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ENLON-PLUS [Atropine Sulfate2C17H23NO3H2OH2O4S : Edrophonium ChlorideC10H16NOCl]
RX
-
0.14mg/ml : 10mg/ml (injection injectable)
Mylan InstitutionalNov 6, 1991
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ISOPTO ATROPINE [Atropine Sulfate2C17H23NO3H2OH2O4S]
RX
-
1% (ophthalmic solution/drops)
Novartis Pharms CorpDec 1, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LOMOTIL [Atropine Sulfate2C17H23NO3H2OH2O4S : Diphenoxylate HydrochlorideC30H32N2O2ClH]
RX
-
0.025mg : 2.5mg (oral tablet)
Gd Searle LlcApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MOTOFEN [Atropine Sulfate2C17H23NO3H2OH2O4S : Difenoxin HydrochlorideC28H28N2O2ClH]
RX
-
0.025mg : 1mg (oral tablet)
Sebela Ireland LtdApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.